Browsed by
Tag: vaccine

Beyond Investment in Research: What COVID-19 Policymakers Can Learn from the HIV/AIDS Epidemic

Beyond Investment in Research: What COVID-19 Policymakers Can Learn from the HIV/AIDS Epidemic

Widespread investment in biomedical research has made many Americans tentatively optimistic about the resolution of the COVID-19 pandemic. In the public sector, the Coronavirus Aid, Relief, and Economic Security (CARES) Act has provided nearly $10 billion in funding for therapy and vaccine development through agencies like the NIH and CDC. This effort has culminated in two important milestones: the discovery that remdesivir, a drug developed to treat Ebola, reduces morbidity for patients hospitalized with severe COVID-19, and the introduction of…

Read More Read More

Vaccines and IP Preparedness in the Coronavirus Outbreak

Vaccines and IP Preparedness in the Coronavirus Outbreak

The COVID-19 pandemic has shed renewed light on the importance of research and development (R&D) on biopharmaceutical products needed to prevent or lessen the burden posed by outbreaks of infectious diseases. Among these, the need for new vaccines has become of paramount importance. While a race to develop different types of vaccines unfolds at unusual speed, there are still significant shortcomings in the ecosystem that leads to the production and dissemination of vaccines targeting infectious diseases like COVID-19. In the…

Read More Read More